help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 25, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1666
A more recent version of this article appeared on February 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/2/492    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coviello, A. D.
Right arrow Articles by Dunaif, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coviello, A. D.
Right arrow Articles by Dunaif, A.

Submitted on July 26, 2005
Accepted on October 17, 2005

Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance

Andrea D. Coviello, Richard S. Legro, and Andrea Dunaif*

Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611; Department of Obstetrics and Gynecology, Pennsylvania State University College of Medicine, Hershey, PA 17033

Context: Adult women with polycystic ovary syndrome (PCOS) have an increased prevalence of the metabolic syndrome (MBS). The prevalence of MBS is also increasing in adolescents.

Objective: To test the hypothesis that the prevalence of MBS is increased in adolescent girls with PCOS compared with the general population and to determine the factors associated with an increased risk of the MBS in PCOS.

Design: Cross-sectional case-control study.

Setting: Academic medical centers with General Clinical Research Center.

Participants: Forty-nine adolescent girls with PCOS and 165 girls from the NHANES III adolescent population of similar age and ethnic background.

Main Outcome Measure: Prevalence of MBS according to currently proposed adolescent MBS criteria.

Results: Thirty-seven percent of adolescent girls with PCOS had MBS compared with 5% of NHANES III girls (P < 0.0001). None of the girls of normal BMI had MBS whereas 11% of overweight and 63% of obese girls with PCOS had MBS compared with 0% and 32% of NHANES III girls, respectively. Girls with PCOS were 4.5 times more likely to have MBS than age matched NHANES III girls after adjusting for BMI (OR 4.5, 95% CI 1.1 - 17.7; P = 0.03).

The odds of having the MBS were 3.8 times higher for every quartile increase in uT in girls with PCOS after adjusting for BMI and insulin resistance (OR 3.8, 95% CI 1.4-10.2, P = 0.008).

Conclusions: Adolescent girls with PCOS have a higher prevalence of MBS than the general adolescent population. Hyperandrogenemia is a risk factor for MBS independent of obesity and insulin resistance.


Key words: Insulin resistance • syndrome X • hyperandrogenemia • androgen disorders • dyslipidemia • hypertension • obesity




This article has been cited by other articles:


Home page
Arch Pediatr Adolesc MedHome page
M. Rachmiel, S. Kives, E. Atenafu, and J. Hamilton
Primary Amenorrhea as a Manifestation of Polycystic Ovarian Syndrome in Adolescents: A Unique Subgroup?
Arch Pediatr Adolesc Med, June 1, 2008; 162(6): 521 - 525.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E. Diamanti-Kandarakis, S. Livadas, S. A Kandarakis, A. Margeli, and I. Papassotiriou
Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
Eur. J. Endocrinol., April 1, 2008; 158(4): 525 - 531.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. S. Ford, C. Li, G. Zhao, W. S. Pearson, and A. H. Mokdad
Prevalence of the Metabolic Syndrome Among U.S. Adolescents Using the Definition From the International Diabetes Federation
Diabetes Care, March 1, 2008; 31(3): 587 - 589.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Rodriguez, D. C. Muller, E. J. Metter, M. Maggio, S. M. Harman, M. R. Blackman, and R. Andres
Aging, Androgens, and the Metabolic Syndrome in a Longitudinal Study of Aging
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3568 - 3572.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Gut Hormones, Obesity, Polycystic Ovarian Syndrome, Malignancy, and Lipodystrophy Syndromes
Diabetes Care, July 1, 2007; 30(7): 1934 - 1939.
[Full Text] [PDF]


Home page
J EndocrinolHome page
A Corbould
Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women
J. Endocrinol., March 1, 2007; 192(3): 585 - 594.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. B. Flowers, A. T. Oler, S. T. Nadler, Y. Choi, K. L. Schueler, B. S. Yandell, C. M. Kendziorski, and A. D. Attie
Abdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E936 - E945.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Nader and E. Diamanti-Kandarakis
Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis
Hum. Reprod., February 1, 2007; 22(2): 317 - 322.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. C. Marshall
Obesity in Adolescent Girls: Is Excess Androgen the Real Bad Actor?
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 393 - 395.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society